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Abstract
Arginine-specific ADP-ribosyltransferase present in secretory granules of chicken polymorphonuclear leukocytes
(so-called heterophils) was shown to be released into the extracellular space by secretagogues (Terashima et al., J. Biochem.
120 (1996) 1209^1215). In the present work, we examined fibronectin as an extracellular target protein of the released
transferase. Fibronectin was ADP-ribosylated by purified transferase and stoichiometry of ADP-ribose incorporation into
fibronectin was 1.0 mol/mol of fibronectin. Cell adhesion and spreading assays revealed that ADP-ribosylation of fibronectin
markedly inhibited the adhesion activity of fibronectin. A proteolytic peptide map of ADP-ribosylated fibronectin
demonstrated that the modification occurs in the cell binding domain of fibronectin. ADP-ribosylation of the RGD peptide
suggests that the RGD sequence is the modification site in the domain. ADP-ribosylation of fibronectin in plasma means that
fibronectin can probably serve as the substrate for extracellularly released ADP-ribosyltransferase in vivo. Thus, in the
extracellular space, ADP-ribosyltransferase released from polymorphonuclear leukocytes may perhaps be involved in
regulation of cell adhesion process by interfering with the activity of fibronectin. 0167-4889 / 98 / $ ^ see front matter ß 1998
Elsevier Science B.V. All rights reserved.
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1. Introduction
Arginine-speci¢c ADP-ribosylation is a post-trans-
lational modi¢cation in which the ADP-ribose moi-
ety of NAD is transferred to the guanidino group of
arginine residues in various proteins and peptides. In
eukaryotes, several arginine-speci¢c ADP-ribosyl-
transferases (ADPRTs) were detected, including rab-
bit skeletal muscle [1,2], human neutrophils [3],
mouse cytotoxic T-cells [4], and chicken polymor-
phonuclear leukocytes [5,6]. The former three trans-
ferases are located on the cell surface via the glyco-
sylphosphatidylinositol (GPI) anchor, and mouse
cytotoxic T-cell ADPRT was shown to be released
by the stimulation of anti-CD3, interleukin 2 or
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phorbol myristate acetate [7]. The skeletal muscle
ADPRT and cytotoxic T-cell ADPRT modify adhe-
sion molecules integrin K7 and lymphocyte function-
associated molecule-1 (LFA-1), respectively [8,9].
These ¢ndings suggest an extracellular ADP-ribosy-
lation and involvement of the modi¢cation in the
control of cell adhesion.
In chicken polymorphonuclear leukocytes, argi-
nine-speci¢c ADPRT is localized in cytoplasmic se-
cretory granules, and is released by secretagogues,
such as calcium ionophore or opsonized-zymosans
[10]. Thus, we asked whether extracellularly released
chicken ADPRT could modify the extracellular ma-
trix protein, such as ¢bronectin (FN), a ligand for
the integrin family. Fibronectin is a major compo-
nent of extracellular matrices and is present as an
adhesive glycoprotein dimer, of which the monomer
has a molecular mass of 235 kDa. It is also present in
plasma at high concentration (0.3 mg/ml). Fibronec-
tin interacts with integrins, collagen, heparin, and
¢brin, and is involved in adhesion, morphological
change, and migration of cells [11]. The ¢bronectin
molecule is composed of type I, II, and III domains,
identi¢ed as repeating amino acid motifs in the pri-
mary structure. The site in FN to promote cell at-
tachment is present in one of the type III domains,
FIII10. The Arg-Gly-Asp (RGD) sequence in the
domain has been shown to be the minimal cell rec-
ognition sequence and thus to be critical for interac-
tion with integrins [12^14]. We show here that chick-
en arginine-speci¢c ADPRT modi¢es FN in plasma,
and that the modi¢cation inhibits the cell adhesion
activity of FN.
2. Materials and methods
2.1. Materials
Chickens were obtained from a local slaughter-
house. [adenylate-32P]NAD (29.6 TBq/mmol) was
purchased from New England Nuclear. Gelatin-
Sepharose and heparin-Sepharose were from Amer-
sham Pharmacia Biotech. RGD peptide and thermo-
lysin were from Sigma. TIG-3 (JCRB0506) and
BALB/3T3 (JCRB9005) cells were obtained from
Health Science Research Resources Bank (HSRRB),
Japan.
2.2. ADP-ribosylation of FN
Fibronectin was puri¢ed from chicken plasma as
described by Hayashi and Yamada [15]. Puri¢ed FN
was incubated with 50 mM Tris-HCl (pH 9.0), 5 mM
dithiothreitol, 50 WM [32P]NAD (3.7 kBq/tube), and
appropriate amounts of ADPRT puri¢ed from chick-
en polymorphonuclear cells [5] in a total volume of
200 Wl at 25‡C for the indicated time. The reaction
was terminated by adding 10% TCA and radioactiv-
ity in the acid-insoluble fraction was measured by
¢lter assay, or analyzed by SDS-PAGE and autora-
diography.
2.3. Cell adhesion assay and phase contrast
microscopic study
Cell adhesion assay and phase contrast micro-
scopic study using TIG-3 or BALB/3T3 cells were
done as described in elsewhere [16]. Fibronectin
(10 Wg) was incubated alone or with NAD (1 mM),
ADPRT (10 ng), or both, in 50 mM Tris-HCl (pH
9.0) and 5 mM dithiothreitol in a plastic tube at 25‡C
for 2 h in a total volume of 100 Wl. We con¢rmed
that 1 mol of ADP-ribose was incorporated into
1 mol of ¢bronectin under these conditions. With
each mixture or PBS, the surface of 96-well £at bot-
tomed plates was coated and kept at 4‡C, overnight.
TIG-3 or BALB/3T3 cells cultured in minimal essen-
tial medium (MEM) containing 10% fetal calf serum
(FCS) were plated on the well at the concentration of
105/ml. Attached cells were stained with 1 mg/ml
methylene blue and intensity of the color was quan-
ti¢ed directly by absorbance at 650 nm. Before stain-
ing, the shape of the attached cells was observed
using phase-contrast microscopy.
2.4. Proteolytic peptide map
Puri¢ed FN (10 Wg) was incubated with 50 mM
Tris-HCl (pH 9.0), 5 mM dithiothreitol, 50 WM
[32P]NAD (37 kBq/tube) and puri¢ed ADPRT
(10 ng) for 30 min at 25‡C in a total volume of
50 Wl. ADP-ribosylation was terminated by adding
1 mM novobiocin, a potent inhibitor of arginine-spe-
ci¢c ADPRT [17], and ADP-ribosylated FN was in-
cubated with thermolysin (1 Wg) according to Seki-
guchi and Hakomori [18] at 25‡C. After 2 h,
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thermolysin (2 Wg) was further added to the reaction
mixture and incubated for an additional 2 h. The
proteolytic reaction was terminated by adding 5
mM ethylenediaminetetraacetic acid (EDTA) and
SDS-PAGE sample bu¡er, and the digested products
were analyzed by SDS-PAGE (12.5% polyacryla-
mide) and autoradiography.
2.5. ADP-ribosylation of FN in chicken plasma
Fresh chicken plasma (800 Wl) collected with 1 mM
EDTA and 0.2 mM PMSF was incubated with 50
WM [32P]NAD (110 kBq), 2 mM ADP-ribose and 500
ng of puri¢ed ADPRT for 1 h at 25‡C in a total
volume of 1 ml. The plasma (800 Wl) was also incu-
bated with 20 WM [32P]NAD (110 kBq) and isolated
chicken polymorphonuclear leukocytes (5U107) [5]
in the presence of 5 WM A23187 and 1 mM CaCl2
[10], for 30 min at 37‡C in a total volume of 1 ml.
After the incubation, 10% PCA-insoluble fraction of
100 Wl of the reaction mixture was analyzed by SDS-
PAGE followed by autoradiography. The remainder
of each mixture was centrifuged at 600Ug for 10 min
and the supernatant was applied to a gelatin-Sephar-
ose column [15] equilibrated with bu¡er A (10 mM
Tris-HCl (pH 7.4), 0.15 M NaCl, and 5 mM EDTA)
and incubated at room temperature for 1 h. After
washing twice with the bu¡er, the bound proteins
were eluted with 1 ml of bu¡er A containing 4 M
urea, precipitated with 10% TCA (w/v), and analyzed
by SDS-PAGE and autoradiography.
3. Results
3.1. ADP-ribosylation of puri¢ed FN
To determine if FN is modi¢ed by arginine-speci¢c
ADPRT from chicken polymorphonuclear leuko-
cytes, FN puri¢ed from chicken plasma was incu-
bated with [32P]NAD in the absence or presence of
the puri¢ed ADPRT, and analyzed by SDS-PAGE
and autoradiography. As shown in Fig. 1A, FN in-
cubated together with [32P]NAD and ADPRT was
radiolabeled; radiolabeling did not occur in the
absence of ADPRT. These results indicate that puri-
¢ed chicken arginine-speci¢c ADPRT apparently
modi¢ed FN. The modi¢cation occurred stoichio-
metrically, and 1 mol of ADP-ribose was incorpo-
rated into 1 mol of FN molecule (Fig. 1B). Further
addition of the enzyme or NAD, or prolonged incu-
bation failed to extend the modi¢cation. The ADP-
ribose^FN linkage was labile to NH2OH, but resist-
ant to HgCl2 [19] (data not shown). These results
con¢rm the ADP-ribosylation of FN on an arginine
residue.
Fig. 1. (A) ADP-ribosylation of puri¢ed FN. FN (5 Wg) was incubated in reaction mixture containing 100 WM [32P]NAD, with or
without puri¢ed chicken ADPRT (10 ng) at 25‡C for 10 min and subjected to SDS-PAGE followed by protein staining (upper) and
autoradiography (lower). (B) Stoichiometry of ADP-ribose incorporated into FN. Puri¢ed FN (2 Wg) was incubated in the reaction
mixture containing 50 WM [32P]NAD and ADPRT (5 ng) at 25‡C for the indicated time. The incorporation of ADP-ribose into the
FN was determined by ¢lter assay.
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3.2. Cell adhesion and spreading activities of
ADP-ribosylated FN
Next, we asked if ADP-ribosylation of FN would
a¡ect its potential to adhere to cells. FN incubated
alone or with NAD, ADPRT, or both, was coated
on the plates and adhesion activity of each FN to-
wards TIG-3 cells was determined by staining of cells
attached to the plate with methylene blue. As shown
in Fig. 2, treatment of FN together with NAD and
ADPRT remarkably decreased cell adhesion, while
FN preincubated alone or either with NAD or
ADPRT adhered to the cells. Phase contrast micros-
copy also clearly showed that TIG-3 cells adhered
and extended on the FN-coated plate, exhibiting a
spread out morphology (Fig. 3A). Cells not adhering
to the ADP-ribosylated FN-coated plate, had a cir-
cular morphology (Fig. 3B). The experiments de-
scribed above were also carried out using BALB/
3T3 cells and similar results were obtained (data
not shown). These studies indicate that the ADP-ri-
bosylation of FN decreased cell adhesion and spread-
ing activities.
3.3. ADP-ribosylation may occur in the cell binding
domain of FN
It was reported that the RGD sequence in the cell
binding domain of FN is the main contributor to the
FN^cell interaction [16,17]. We then looked to see
if the modi¢cation site locates in the cell binding
domain. When [32P]ADP-ribosylated FN was di-
gested with thermolysin, radiolabeling was observed
at the 105 kDa fragment, which contains cell binding
domain [18,20] (Fig. 4). Moreover, ADP-ribosylation
of RGD peptide was con¢rmed by reverse-phase
HPLC (data not shown). These ¢ndings support
the notion of a modi¢cation of the RGD sequence
in the cell binding domain. We propose that inhi-
bition of cell adhesion and spreading activities of
FN by ADP-ribosylation may be attributed to mod-
i¢cation of the RGD sequence in the cell binding
domain.
Fig. 3. E¡ect of ADP-ribosylation on cell spreading activity of
FN. Phase contrast micrographs of TIG-3 cells cultured for 2 h
on plastic plates coated with 10 Wg/ml of FN preincubated (A)
alone, or (B) in the presence of NAD and ADPRT at U400
magni¢cation.
Fig. 2. E¡ect of ADP-ribosylation on cell adhesion activity of
FN. Cell adhesion assays of FN (10 Wg) preincubated alone (1),
or with NAD (2), ADPRT (3) or NAD and ADPRT (4) were
done as described in Section 2. The data are the mean þ S.D. of
three experiments conducted in triplicate.
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3.4. ADP-ribosylation of FN in chicken plasma
To observe if FN could serve as the substrate for
the released ADPRT from chicken polymorphonu-
clear leukocytes [10], chicken plasma was incubated
with [32P]NAD and puri¢ed ADPRT, and then
placed on to a gelatin-Sepharose column to isolate
the FN [18]. The acid-insoluble fraction of proteins
eluted with 4 M urea from the column was analyzed
by SDS-PAGE. After autoradiography, the radioac-
tivity was detected at a band with a molecular mass
of 230 kDa, which corresponds in size to FN (Fig. 5,
lane 1). The 67 kDa protein appeared in Coomassie
brilliant blue staining was probably contaminated
albumin. When chicken polymorphonuclear leuko-
cytes were stimulated with 5 WM A23187 and 1
mM CaCl2 in chicken plasma in the presence of
[32P]NAD, labeling of FN was also observed (Fig.
5, lane 2). These data suggest that ADP-ribosylation
of FN might possibly occur in vivo.
4. Discussion
Fibronectin serves as a target for glycosylation,
phosphorylation, sulfation, and acylation [13,21^
23]. Although the glycosylation of FN protects the
protein against proteolysis and provides useful cell-
type-speci¢c markers [21], the signi¢cance of other
post-translational modi¢cations of FN is unknown.
We found that ADP-ribosylation of FN decreases its
cell adhesion and spreading activities, perhaps
through a modi¢cation of the RGD sequence in
the cell binding domain of FN. This is apparently
the ¢rst report demonstrating that FN is ADP-ribo-
sylated and we suggest that this modi¢cation may
have a role in regulating the cell adhesion activity
of FN.
Fibronectin is a glycoprotein present in extracellu-
lar matrices and in plasma, and plays important roles
in a variety of biological processes. Fibronectin binds
heterodimeric integrins, including K5L1, K3L1, KvL1,
KvL3 and KIIbL3 via its cell binding domain contain-
ing FIII10. Occupation of these integrin receptors
Fig. 5. ADP-ribosylation of FN in plasma. Fresh chicken plas-
ma was incubated with 50 WM [32P]NAD and puri¢ed ADPRT
(lane 1), or with 20 WM [32P]NAD and chicken polymorphonu-
clear leukocytes in the presence of secretagogues (lane 2), as de-
scribed in Section 2, and applied to a gelatin-Sepharose column.
The eluate with 4 M urea was analyzed using SDS-PAGE fol-
lowed by protein staining (A) and autoradiography (B).
Fig. 4. Proteolytic peptide map of ADP-ribosylated FN.
[32P]ADP-ribosylated FN was digested with thermolysin as de-
scribed in Section 2, and fractionated with SDS-PAGE followed
by Coomassie brilliant blue staining (upper) and autoradiogra-
phy (lower).
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with extracellular matrix proteins, such as FN, leads
to tyrosine phosphorylation of the proteins and cy-
toplasmic alkalinization, which leads to activation,
proliferation or interleukin production in lympho-
cytes, and proliferation or migration in ¢broblasts
[24].
A synergic region FIII9 was found to be required
for the biological activity of FN [25,26]. Moreover,
crystal structure of FIII7^FIII10 of human FN indi-
cates that FIII9 and FIII10 are on the same surface
of FN and easily access to a single integrin molecule
[27]. Thus, ADP-ribosylation may directly obscure
the protruding RGD sequence on the cell binding
domain or indirectly disrupt the ‘synergy’ e¡ect be-
tween FIII9 and FIII10, thereby possibly inhibiting
FN^cell interactions. The precise mechanism, by
which ADP-ribosylation decrease the cell adhesion
activity of FN, and the site of ADP-ribosylation
are now being examined.
ADP-ribosyltransferases, attaching to the outer
surface of skeletal muscle myoblasts and mouse cy-
totoxic T-cells via the GPI-anchor, have been shown
to modify integrin K7 [8] and LFA-1 [9], respectively.
These modi¢cations occurring on the cell surface
might inhibit cell aggregation or transmembrane sig-
naling through an as yet to be determined mecha-
nism. ADP-ribosyltransferase of chicken polymor-
phonuclear leukocytes is released into extracellular
spaces by secretagogues [10]. ADP-ribosylation of
FN by stimulated polymorphonuclear leukocytes in
plasma suggests a possible modi¢cation in vivo. Hu-
man neutrophils also possess arginine-speci¢c
ADPRT activities in cells [3]. Thus, ADPRTs dis-
persed into extracellular space, might regulate extra-
cellular matrix functions, by modifying FN in cellu-
lar processes, such as cell attachment, migration, and
proliferation, during in£ammation or wound healing.
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